Effect of 5-year continuous positive airway pressure treatment on MMPs and TIMPs: implications for OSA comorbidities.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
25 05 2020
25 05 2020
Historique:
received:
09
01
2020
accepted:
27
04
2020
entrez:
27
5
2020
pubmed:
27
5
2020
medline:
2
12
2020
Statut:
epublish
Résumé
Continuous positive airway pressure (CPAP) treatment results in nearly complete remission of symptoms of obstructive sleep apnoea (OSA); however, its effect on OSA comorbidities including cardiovascular diseases remains contradictory. Here we investigated the short- and long-term effect of CPAP treatment on matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in patients with severe OSA. Serum levels of 7 MMPs and 3 TIMPs were followed in OSA patients (n = 28) with an apnoea-hypopnoea index of ≥30 events/h at the time of diagnosis and at control visits (2 months, 6 months and 5 years) after initiation of fixed-pressure CPAP treatment. The first few months of CPAP therapy resulted in significant decrease of MMP-8 and MMP-9 levels (MMP-8: 146 (79-237) vs. 287 (170-560) pg/mL; MMP-9: 10.1 (7.1-14.1) vs. 12.7 (10.4-15.6) ng/mL, p < 0.05 for each at 2 months), while the rest of the panel remained unchanged as compared to baseline values. In contrast, at 5 years, despite of uninterrupted CPAP treatment and excellent adherence the levels of MMP-8, MMP-9 and TIMPs significantly increased (p < 0.05). Our data suggest that initiation of CPAP therapy leads to a decrease in the level of key MMPs in the short-term; however, this effect is not sustained over the long-term.
Identifiants
pubmed: 32451401
doi: 10.1038/s41598-020-65029-6
pii: 10.1038/s41598-020-65029-6
pmc: PMC7248085
doi:
Substances chimiques
Tissue Inhibitor of Metalloproteinases
0
Matrix Metalloproteinases
EC 3.4.24.-
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
8609Références
Eisele, H. J., Markart, P. & Schulz, R. Obstructive sleep apnea, oxidative stress, and cardiovascular disease: evidence from human studies. Oxid. Med. Cell. Longev. 2015, 608438, https://doi.org/10.1155/2015/608438 (2015).
doi: 10.1155/2015/608438
pubmed: 26167241
pmcid: 4475750
Bradley, T. D. & Floras, J. S. Obstructive sleep apnoea and its cardiovascular consequences. Lancet 373, 82–93, https://doi.org/10.1016/S0140-6736(08)61622-0 (2009).
doi: 10.1016/S0140-6736(08)61622-0
pubmed: 19101028
Johnson, J. L. Metalloproteinases in atherosclerosis. Eur. J. Pharmacol 816, 93–106, https://doi.org/10.1016/j.ejphar.2017.09.007 (2017).
doi: 10.1016/j.ejphar.2017.09.007
pubmed: 28893577
Myasoedova, V. A., Chistiakov, D. A., Grechko, A. V. & Orekhov, A. N. Matrix metalloproteinases in pro-atherosclerotic arterial remodeling. J. Mol. Cell. Cardiol. 123, 159–167, https://doi.org/10.1016/j.yjmcc.2018.08.026 (2018).
doi: 10.1016/j.yjmcc.2018.08.026
pubmed: 30172754
Tan, C. H. et al. Associations of matrix metalloproteinase-9 and monocyte chemoattractant protein-1 concentrations with carotid atherosclerosis, based on measurements of plaque and intima-media thickness. Atherosclerosis 232, 199–203, https://doi.org/10.1016/j.atherosclerosis.2013.11.040 (2014).
doi: 10.1016/j.atherosclerosis.2013.11.040
pubmed: 24401238
Heo, S. H. et al. Plaque rupture is a determinant of vascular events in carotid artery atherosclerotic disease: involvement of matrix metalloproteinases 2 and 9. J. Clin. Neurol. 7, 69–76, https://doi.org/10.3988/jcn.2011.7.2.69 (2011).
doi: 10.3988/jcn.2011.7.2.69
pubmed: 21779294
pmcid: 3131541
Blankenberg, S. et al. Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease. Circulation 107, 1579–1585, https://doi.org/10.1161/01.CIR.0000058700.41738.12 (2003).
doi: 10.1161/01.CIR.0000058700.41738.12
pubmed: 12668489
Löffek, S., Schilling, O. & Franzke, C. W. Series “matrix metalloproteinases in lung health and disease”: Biological role of matrix metalloproteinases: a critical balance. Biological role of matrix metalloproteinases: a critical balance. Eur. Resp. J. 38, 191–208, https://doi.org/10.1183/09031936.00146510 (2011).
doi: 10.1183/09031936.00146510
Hopps, E. & Caimi, G. Obstructive sleep apnea syndrome: links between pathophysiology and cardiovascular complications. Clin. Invest. Med 38, E362–E370, https://doi.org/10.25011/cim.v38i6.26199 (2015).
doi: 10.25011/cim.v38i6.26199
pubmed: 26654519
Ye, J., Liu, H., Li, Y., Liu, X. & Zhu, J. Increased serum levels of C-reactive protein and matrix metalloproteinase-9 in obstructive sleep apnea syndrome. Chin. Med. J. 120, 1482–1486, https://doi.org/10.1097/00029330-200709010-00003 (2007).
doi: 10.1097/00029330-200709010-00003
pubmed: 17908454
Chuang, L. P. et al. Increased matrix metalloproteinases-9 after sleep in plasma and in monocytes of obstructive sleep apnea patients. Life. Sci. 93, 220–225, https://doi.org/10.1016/j.lfs.2013.06.009 (2013).
doi: 10.1016/j.lfs.2013.06.009
pubmed: 23792205
Yüksel, M., Kuzu-Okur, H., Velioğlu-Öğünç, A. & Pelin, Z. Matrix metalloproteinase-9 level and gene polymorphism in sleep disordered breathing patients with or without cardiovascular disorders. Balkan. Med. J 30, 8–12, https://doi.org/10.5152/balkanmedj.2012.068 (2013).
doi: 10.5152/balkanmedj.2012.068
pubmed: 25207060
Wang, S., Li, S., Wang, B., Liu, J. & Tang, Q. Matrix metalloproteinase-9 is a predictive factor for systematic hypertension and heart dysfunction in patients with obstructive sleep apnea syndrome. Biomed. Res. Int. 2018, 1569701, https://doi.org/10.1155/2018/1569701 (2018).
doi: 10.1155/2018/1569701
pubmed: 29693002
pmcid: 5859852
Christou, K. et al. Nasal continuous positive airway pressure treatment reduces systemic oxidative stress in patients with severe obstructive sleep apnea syndrome. Sleep Med. 10, 87–94, https://doi.org/10.1016/j.sleep.2007.10.011 (2009).
doi: 10.1016/j.sleep.2007.10.011
pubmed: 18077211
Tazaki, T. et al. Increased levels and activity of matrix metalloproteinase-9 in obstructive sleep apnea syndrome. Am. J. Respir. Crit. Care Med. 170, 1354–1359, https://doi.org/10.1164/rccm.200402-193OC (2004).
doi: 10.1164/rccm.200402-193OC
pubmed: 15361365
Kaditis, A. G. et al. Adiposity and low-grade systemic inflammation modulate matrix metalloproteinase-9 levels in Greek children with sleep apnea. Pediatr. Pulmonol. 45, 693–699, https://doi.org/10.1002/ppul.21251 (2010).
doi: 10.1002/ppul.21251
pubmed: 20575100
Yu, J. et al. Association of positive airway pressure with cardiovascular events and death in adults with sleep apnea: a systematic review and meta-analysis. JAMA 318, 156–166, https://doi.org/10.1001/jama.2017.7967 (2017).
doi: 10.1001/jama.2017.7967
pubmed: 28697252
pmcid: 5541330
Martinez-Garcia, M. A., Campos-Rodriguez, F., Javaheri, S. & Gozal, D. Pro: continuous positive airway pressure and cardiovascular prevention. Eur. Respir. J. 51, pii: 1702400, https://doi.org/10.1183/13993003.02400-2017 (2018).
doi: 10.1183/13993003.02400-2017
McEvoy, R.D. & Kohler, M. Con: continuous positive airway pressure and cardiovascular prevention. Eur. Respir. J. 51, pii: 1702721, https://doi.org/10.1183/13993003.02721-2017 (2018).
doi: 10.1183/13993003.02721-2017
Bikov, A. et al. Comprehensive coronary plaque assessment in patients with obstructive sleep apnea. J. Sleep. Res., e12828. https://doi.org/10.1111/jsr.12828 (2019).
Franczak, A. et al. Matrix metalloproteinases as possible biomarkers of obstructive sleep apnea severity - A systematic review. Sleep Med. Rev. 46, 9–16, https://doi.org/10.1016/j.smrv.2019.03.010 (2019).
doi: 10.1016/j.smrv.2019.03.010
pubmed: 31060030
Roberts, C. K., Chen, A. K. & Barnard, R. J. Effect of a short-term diet and exercise intervention in youth on atherosclerotic risk factors. Atherosclerosis 191, 98–106, https://doi.org/10.1016/j.atherosclerosis.2006.09.011 (2007).
doi: 10.1016/j.atherosclerosis.2006.09.011
pubmed: 17054960
Berg, G., Barchuk, M. & Miksztowicz, V. Behavior of metalloproteinases in adipose tissue, liver and arterial wall: an update of extracellular matrix remodeling. Cells 8, pii: E158, https://doi.org/10.3390/cells8020158 (2019).
doi: 10.3390/cells8020158
Simon, B. et al. Effect of 5-year continuous positive airway pressure treatment on the lipid profile of patients with obstructive sleep apnea: a pilot study. J. Sleep. Res. e12874, https://doi.org/10.1111/jsr.12874 (2019).
Antus, B. et al. Assessment of exhaled breath condensate pH in exacerbations of asthma and chronic obstructive pulmonary disease: a longitudinal study. Am. J. Respir. Crit. Care Med. 182, 1492–1497, https://doi.org/10.1164/rccm.201003-0451OC (2010).
doi: 10.1164/rccm.201003-0451OC
pubmed: 20656939